Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aquinox Pharmaceutic (NQ: AQXP )

N/A USD UNCHANGED
Last Price Updated: 4:13 PM EDT, Aug 9, 2019 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Aquinox Pharmaceutic

< Previous 1 2 3 Next >
Neoleukin Therapeutics and Aquinox Pharmaceuticals Complete Merger Transaction
From GlobeNewswire News Releases
Neoleukin Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference
From GlobeNewswire News Releases
Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement
From GlobeNewswire News Releases
Ventas Appoints Sean P. Nolan to Board of Directors
Ventas, Inc. (NYSE: VTR) announced that Sean P. Nolan, former Chief Executive Officer of AveXis, Inc. (formerly NASDAQ: AVXS), a clinical-stage gene therapy company, has been appointed as an... 
From Business Wire News Releases
Aquinox Pharmaceuticals Announces Third Quarter 2018 Financial Results
Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers, today... 
From GlobeNewswire News Releases
Consolidated Research: 2018 Summary Expectations for Aquinox Pharmaceuticals, Xilinx, West Pharmaceutical Services, nVent Electric, World Wrestling Entertainment, and HD Supply — Fundamental Analysis,
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Aquinox Pharmaceuticals,... 
From GlobeNewswire News Releases
Aquinox Pharmaceuticals Announces Second Quarter 2018 Financial Results
Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers, today... 
From GlobeNewswire News Releases
These Small Biotech Companies Could Bring a 300% Return Before end of the Year
From ACCESSWIRE
Aquinox Announces Topline Results of Phase 3 LEADERSHIP 301 Clinical Trial in Interstitial Cystitis/Bladder Pain Syndrome
Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), today announced that the Phase 3 LEADERSHIP 301 clinical trial evaluating once-daily, oral rosiptor (AQX-1125) for the treatment of interstitial... 
From GlobeNewswire News Releases
Aquinox Pharmaceuticals Announces Initiation of ProShip Phase 2 Proof-of-Concept Clinical Trial Investigating Rosiptor in CP/CPPS
Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood... 
From GlobeNewswire News Releases
Aquinox to Present at 2018 UBS Global Healthcare Conference
Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood... 
From GlobeNewswire News Releases
Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) (“Aquinox”), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood... 
From GlobeNewswire News Releases
Aquinox Pharmaceuticals Announces First Quarter 2018 Financial Results
Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood... 
From GlobeNewswire News Releases
Aquinox to Present at Deutsche Bank 43rd Annual Healthcare Conference
Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood... 
From GlobeNewswire News Releases
Aquinox to Present at 2018 Bloom Burton & Co. Healthcare Conference
Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood... 
From GlobeNewswire News Releases
Aquinox to Present at the 17th Annual Needham Healthcare Conference
Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood... 
From GlobeNewswire News Releases
Aquinox Pharmaceuticals Announces Year End 2017 Financial Results
From GlobeNewswire News Releases
Aquinox Pharmaceuticals to Announce Year End 2017 Financial Results
Conference call Monday March 12, 2018 at 4:30 PM ET 
From GlobeNewswire News Releases
Aquinox Provides Enrollment Update for LEADERSHIP 301 Clinical Trial of Rosiptor
Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood... 
From GlobeNewswire News Releases
Aquinox to Present at LEERINK Partners 7th Annual Global Healthcare Conference
Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood... 
From GlobeNewswire News Releases
Aquinox to Host Analyst and Investor Event in New York City
External Expert, Management to Present on IC/BPS and Clinical Development Program 
From GlobeNewswire News Releases
Aquinox Promotes Lloyd Mackenzie to Chief Operating Officer and Vice President, R&D Operations
Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP) today announced that Lloyd Mackenzie has been promoted, effective immediately, to the newly created position of Chief Operating Officer and Vice... 
From GlobeNewswire News Releases
Aquinox Statement on FDA Advisory Committee Meeting to Discuss Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,... 
From GlobeNewswire News Releases
Aquinox to Participate in 29th Annual Piper Jaffray Healthcare Conference
Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,... 
From GlobeNewswire News Releases
Aquinox Pharmaceuticals Announces Third Quarter 2017 Financial Results
Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,... 
From GlobeNewswire News Releases
Aquinox to Present at 2017 Cantor Fitzgerald Global Healthcare Conference
Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,... 
From GlobeNewswire News Releases
Aquinox Statement on FDA Advisory Committee Meeting to Discuss Interstitial Cystitis/Bladder Pain Syndrome
Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology... 
From GlobeNewswire News Releases
Analyzing the Financial Health of Biotech Companies
Microcapspeculators.com News Commentary 
From PR Newswire
Aquinox Pharmaceuticals Announces Second Quarter 2017 Financial Results
Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,... 
From GlobeNewswire News Releases
Aquinox to Present at Canaccord Genuity 37th Annual Growth Conference
Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,... 
From GlobeNewswire News Releases
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.